Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 78.56B | 79.54B | 76.53B | 72.27B | 80.07B | 78.76B |
Gross Profit | 27.51B | 27.28B | 27.47B | 26.83B | 29.19B | 28.95B |
EBITDA | 6.01B | 8.26B | 8.61B | 10.39B | 10.34B | 12.27B |
Net Income | 2.97B | 2.44B | 2.59B | 5.07B | 3.71B | 4.16B |
Balance Sheet | ||||||
Total Assets | 42.78B | 40.85B | 38.70B | 39.23B | 56.08B | 55.85B |
Cash, Cash Equivalents and Short-Term Investments | 5.32B | 4.33B | 2.31B | 3.58B | 5.37B | 5.62B |
Total Debt | 20.06B | 19.67B | 18.12B | 17.05B | 31.88B | 33.83B |
Total Liabilities | 30.98B | 30.14B | 27.78B | 27.21B | 44.28B | 46.26B |
Stockholders Equity | 11.73B | 10.64B | 10.86B | 11.99B | 11.78B | 9.57B |
Cash Flow | ||||||
Free Cash Flow | 2.01B | -291.00M | 2.82B | 2.66B | 4.84B | 6.60B |
Operating Cash Flow | 5.35B | 2.84B | 6.17B | 5.14B | 6.70B | 8.03B |
Investing Cash Flow | -1.35B | -570.00M | -3.93B | -2.46B | -1.85B | 5.91B |
Financing Cash Flow | -2.59B | 336.00M | -4.40B | -5.16B | -5.10B | -13.52B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
77 Outperform | 1.93B | 9.09 | 5.30% | 5.08% | -7.23% | -27.81% | |
77 Outperform | 9.30B | 16.35 | 30.00% | 4.36% | -2.44% | -10.74% | |
75 Outperform | 3.87B | 31.00 | 7.64% | 1.29% | -1.63% | -72.22% | |
62 Neutral | $2.82B | 20.13 | 22.76% | 4.06% | 7.08% | -1.75% | |
62 Neutral | 4.67B | 9.90 | 11.12% | 4.14% | -3.43% | 169.28% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% |